No brainer in my opinion. Just look at the numbers. Look at the growth. Look at the product portfolio. This shouldn't be in the 0.03s for long. If MJ*A and RM*B can trade at the prices they're at, with minimal earnings, and with larger share structures, comparably speaking, it shouldn't be a question of IF POTN can see a similar/better share price but when. Just my opinion here. I'm a big CBD supporter and invest in a few of these kinds of plays.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.